Skip to main content
SpringerLink
Log in

The Prognostic Value of the Metabolic Tumor Volume in FIGO stage IA to IIB Cervical Cancer for Tumor Recurrence: Measured by F-18 FDG PET/CT

  • Original Article
  • Published:
Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to evaluate the prognostic value of the metabolic tumor volume (MTV), in FIGO stage IA–IIB cervical cancer patients, measured by F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) imaging.

Methods

Forty-five patients with invasive cervical cancer who underwent FDG-PET imaging were recruited. Metabolically active tumor regions were delineated on the pretreatment FDG-PET scans by encompassing regions equal to or greater than an standardized uptake value (SUV) of 40% of the peak tumor intensity. The relationship of the metabolic tumor volume (MTV) to the disease-free survival was analyzed. The MTV of the cervical cancer was compared with pathological and clinical prognostic factors, including lymph node metastasis, parametrial invasion, the depth of invasion, resection margins, tumor differentiation and FIGO stages.

Results

Cox proportional hazard regression analysis showed that the MTV was a significant independent predictor of recurrence of cervical cancer (p = 0.027). Patients with an MTV of >20 cm3 had a significantly reduced disease-free survival compared with patients with an MTV ≤ 20 cm3 (p = 0.029). The correlation of the MTV with traditional prognostic factors showed significantly higher values in patients that were lymph node (LN) metastasis positive (p = 0.028) and parametrial invasion positive (p = 0.022). The MTV significantly differed among the groups according to tumor differentiation (p = 0.0319) and FIGO stage (p = 0.001).

Conclusion

The MTV measured by FDG-PET was an independent prognostic factor for tumor recurrence in patients with stage IA–IIB cervical cancer. These findings must be confirmed by large population based prospective studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jermal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin. 2009;59:225–49.

    Article  Google Scholar 

  2. Lee YY, Choi CH, Kim CJ, Kang H, Kim TJ, LEE JW, et al. The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results. Gynecol Oncol. 2009;115:65–8.

    Article  PubMed  Google Scholar 

  3. Conti PS, Lilien DL, Hawley K, Keppler J, Grafton ST, Bading JR. PET and 18 F-FDG in oncology: a clinical update. Nucl Med Biol. 1996;23:717–35.

    Article  CAS  PubMed  Google Scholar 

  4. Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jersalem G, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med. 1996;23:1641–74.

    Article  CAS  PubMed  Google Scholar 

  5. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med. 2001;42:1S–93.

    CAS  PubMed  Google Scholar 

  6. Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol. 1999;17:41–5.

    CAS  PubMed  Google Scholar 

  7. Wong TZ, Jones EL, Coleman RE. Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-d-glucose for evaluating local and distant disease in patients with cervical cancer. Mol Imag Biol. 2004;6:55–62.

    Article  Google Scholar 

  8. Miller TR, Pinkus E, Dehdashti F, Grigsby PW. Improved prognostic value of 18 F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer. J Nucl Med. 2003;44:192–7.

    PubMed  Google Scholar 

  9. Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. The SUV for 18FDG-PET is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer. 2007;110:1738–44.

    Article  PubMed  Google Scholar 

  10. Husain A, Akhurst T, Larson S, Alektiar K, Barakat RR, Chi DS. A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration. Gynecol Oncol. 2007;106:177–80.

    Article  CAS  PubMed  Google Scholar 

  11. Lee P, Weerasuriya DK, Lavori PW, Quon A, Hara W, Maxim PG, et al. Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007;69:328–33.

    Article  PubMed  Google Scholar 

  12. Seol YM, Kwon BR, Song MK, Choi YJ, Shin HJ, Chung JS, et al. Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy. Acta Oncol. 2010;49:201–8.

    Article  CAS  PubMed  Google Scholar 

  13. Miller TR, Grigsby PW. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys. 2002;53:353–9.

    Article  PubMed  Google Scholar 

  14. Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JPA. 18 F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst. 2008;100:712–20.

    Article  PubMed  Google Scholar 

  15. Chan SC, Chang JT, Wang HM, Lin CY, Ng SH, Fan KH, et al. Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value. Oral Oncol. 2009;45:52–8.

    Article  PubMed  Google Scholar 

  16. Eschmann SM, Friedel G, Paulsen F, Reimold M, Hehr T, Budach W, et al. Is standardized (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer? Eur J Nucl Med Mol Imaging. 2006;33:263–9.

    Article  CAS  PubMed  Google Scholar 

  17. Shapiro M, Yun M, junkins-Hopkins JM, Vittorio CC, Schulman N, Saidman BH, et al. Assessment of tumor burden and treatment response by 18 F-fluorodeoxyglucose positron emission tomography in patients with cutaneous T- and B-cell lymphoma. J Am Acad Dermatol. 2002;47:623–8.

    Article  PubMed  Google Scholar 

  18. Alvarez RD, Potter ME, Soong SJ, Gay FL, Hatch KD, Partridge EE, et al. Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage Ib cervical cancer patients. Gynecol Oncol. 1991;43:108–12.

    Article  CAS  PubMed  Google Scholar 

  19. Sethi TK, Bhalla NK, jena AN, Rawat S, Orberoi R. Magnetic resonance imaging in carcinoma cervix-does in have a prognostic relevance. J Cancer Res Ther. 2005;1:103–7.

    Article  PubMed  Google Scholar 

  20. Plataniotis GA, Theofanopoulou ME, Kalogera-Fountzila A, Haritanti A, Ciuleanou E, Ghilezan N. Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or mbined radiochemotherapy in a randomized trial. Int J Radiat Oncol Biol Phys. 2004;59:1018–26.

    Article  PubMed  Google Scholar 

  21. Bradley JD, leumwananonthachi N, Purdy JA, Wasserman TH, Lockett MA, Graham MV, et al. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys. 2002;52:49–57.

    Article  PubMed  Google Scholar 

  22. Xie P, Yue JB, Zhao HX, Sun XD, Kong L, Fu Z, et al. Prognostic value of F-18 FDG PET-CT metabolic index for nasopharyngeal carcinoma. J Cancer Res Clin Oncol. 2009. doi:10.1007/s00432-009-0729-7. Nov 20 [Epub ahead of print].

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Pusan National University School of Medicine, Busan, Republic of Korea

    Bum Soo Kim, In Joo Kim, Seong-Jang Kim, Hyun-Yeol Nam, Kyoung June Pak & Keunyoung Kim

  2. Medical Research Institute, Pusan National University School of Medicine, Busan, Republic of Korea

    In Joo Kim, Seong-Jang Kim & Man Soo Yun

  3. Department of Gynecology and Oncology, Pusan National University School of Medicine, Busan, Republic of Korea

    Man Soo Yun

  4. Department of Nuclear Medicine, Pusan National University Hospital and Medical Research Institute, Pusan National University, Busan, Republic of Korea

    In Joo Kim

Authors
  1. Bum Soo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. In Joo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seong-Jang Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hyun-Yeol Nam
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kyoung June Pak
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Keunyoung Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Man Soo Yun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to In Joo Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, B.S., Kim, I.J., Kim, SJ. et al. The Prognostic Value of the Metabolic Tumor Volume in FIGO stage IA to IIB Cervical Cancer for Tumor Recurrence: Measured by F-18 FDG PET/CT. Nucl Med Mol Imaging 45, 36–42 (2011). https://doi.org/10.1007/s13139-010-0062-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13139-010-0062-8

Keywords

Search

Navigation